A Real-world Study of Inclisiran Adherence, Treatment Patterns, Patient Characteristics, and Effectiveness in ASCVD Patients With Hypercholesterolemia, ASCVD-risk Equivalent Patients With Hypercholesterolemia and Familial Hypercholesterolemia

Clinical trial NCT06507852 · COMPLETED

Trial details

NCT number: NCT06507852
Sponsor: Novartis
Status: COMPLETED
Study type: OBSERVATIONAL

Atherosclerotic Cardiovascular Disease Hypercholesterolemia

Start date: 2022-10-03
Primary completion: 2023-07-06
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.